omni
aaps
Is It Time To Say Goodbye To ClinicalTrials.Gov?
Is It Time To Say Goodbye To ClinicalTrials.Gov?
It is an exciting time in the pharmaceutical industry. According to industry organization PHRMA, there are currently more than 7,000 new medicines under development with many being first in class treatments. Digital technology combined with medicine, g...
AI Provides New Insights for Accelerated Drug Development
AI Provides New Insights for Accelerated Drug Development
The enormous cost associated with drug development is one of the biggest challenges for pharmaceutical manufacturers. With an estimated cost of $2.6 billion and more than 10 years (1) to develop and test a drug candidate, the pharmaceutical industr...
3 Trends in Pharma Globalization
3 Trends in Pharma Globalization
Nearly 60 to 70 percent of the healthcare market is still dominated by North America, and many smaller biopharma companies are reluctant to move beyond the established markets of the U.S., Europe and Japan.
Serialization Will Be Good For Business, Pharma Says
Serialization Will Be Good For Business, Pharma Says
More than 70 percent of drugmakers believe serialization requirements in the U.S. will positively transform their business processes, according to a new report.
How Might Biopharma Manufacturing Differ In The Next Decade?
How Might Biopharma Manufacturing Differ In The Next Decade?
When embarking on our pulling together the manufacturing outlook article for our December 2017 issue, we faced what many might describe as a good problem to have - too much content and not enough pages.